Search Results - "Husson, J. M"

Refine Results
  1. 1

    Guidance synthesis. Medical research for and with older people in Europe: Proposed ethical guidance for good clinical practice: Ethical considerations by Diener, L, Hugonot-Diener, L, Alvino, S, Baeyens, J. P, Bone, M. P, Chirita, D, Husson, J. M, Maman, M, Piette, F, Tinker, A, Von Raison, F

    Published in The Journal of nutrition, health & aging (01-07-2013)
    “…INTRODUCTION: In Europe the population is ageing rapidly. Older people are taking many medicinal products daily and these may not necessarily be suitable for…”
    Get full text
    Journal Article
  2. 2

    Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK by Bickerstaffe, R, Brock, P, Husson, J-M, Rubin, I, Bragman, K, Paterson, K, Sommerville, A

    “…The practice of pharmaceutical medicine brings with it ethical challenges and dilemmas often very different from those encountered in the practice of clinical…”
    Get more information
    Journal Article
  3. 3

    Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK by Bickerstaffe, R, Brock, P, Husson, J-M, Rubin, I, Bragman, K, Paterson, K, Sommerville, A

    “…Medical practitioners practising in the field of pharmaceutical medicine, whether in industry, regulatory bodies or an academic environment, are bound by the…”
    Get more information
    Journal Article
  4. 4

    The new steroid analog RU 486 inhibits glucocorticoid action in man by Bertagna, X, Bertagna, C, Luton, J P, Husson, J M, Girard, F

    “…RU 486 [17 beta-hydroxy-11 beta-(4- dimethylaminophenyl )-17 alpha-(prop-1- ynyl )-estra-4,9-dien-3-one] is a new steroid analog which antagonizes…”
    Get more information
    Journal Article
  5. 5

    New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens by Labrie, F, Dupont, A, Belanger, A, Lacoursiere, Y, Raynaud, J P, Husson, J M, Gareau, J, Fazekas, A T, Sandow, J, Monfette, G

    Published in The Prostate (1983)
    “…To completely eliminate androgens of both testicular and adrenal origin, 37 previously untreated patients with advanced (stages C or D) prostatic cancer…”
    Get more information
    Journal Article
  6. 6

    Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome by Bertagna, X, Bertagna, C, Laudat, M H, Husson, J M, Girard, F, Luton, J P

    “…RU 486 [17 beta-hydroxy-11 beta-(4-dimethylaminophenyl)17 alpha-(prop-1-ynyl)estra-4,9-dien-3-one] is a steroid analog which antagonizes glucocorticoid action…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid by Erlinger, S, Le Go, A, Husson, J M, Fevery, J

    Published in Hepatology (Baltimore, Md.) (01-03-1984)
    “…A double-blind randomized, multicenter study was carried out to determine the efficacy and safety of ursodeoxycholic acid (UDCA) at 4 doses of 2.1 to 16.2 mg X…”
    Get more information
    Journal Article
  9. 9

    Are basal Ediacaran (635 Ma) post-glacial “cap dolostones” diachronous? by Hoffman, Paul F., Halverson, Galen P., Domack, Eugene W., Husson, Jonathan M., Higgins, John A., Schrag, Daniel P.

    Published in Earth and planetary science letters (15-06-2007)
    “…A layer of shallow-water dolostone (“cap dolostone”) with idiosyncratic sedimentary structures was deposited across continental margins world-wide in the…”
    Get full text
    Journal Article
  10. 10

    Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism by ULMANN, A, BERTAGNA, C, LE GO, A, HUSSON, J. M, TACHE, A, MENARD, J, CORVOL, P

    Published in European journal of clinical pharmacology (01-01-1985)
    “…The antimineralocorticoid effect of a single dose of RU 28318, has been assessed in healthy men with exogenous or endogenous hypermineralocorticism. For…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide) by Kuhn, J M, Billebaud, T, Navratil, H, Moulonguet, A, Fiet, J, Grise, P, Louis, J F, Costa, P, Husson, J M, Dahan, R

    Published in The New England journal of medicine (17-08-1989)
    “…Gonadotropin-releasing hormone (GnRH) analogues administered for the treatment of advanced prostatic cancer induce a transient increase in plasma testosterone…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Streptokinase after late failure of reconstructive surgery for peripheral arteriosclerosis by Husson, J M, Fiessinger, J N, Aiach, M, Cormier, J M, Housset, E

    Published in Journal of cardiovascular surgery (01-03-1981)
    “…After the failure of reconstructive surgery for arterial occlusions of the lower limbs, 25 patients with severe ischemia were treated with streptokinase (SK)…”
    Get more information
    Journal Article
  15. 15

    RU 16117, an orally active estriol-like weak estrogen by Raynaud, J P, Azadian-Boulanger, G, Bouton, M M, Colin, M C, Faure, N, Fernand-Proulx, L, Gautray, J P, Husson, J M, Jolivet, A, Kelly, P

    Published in Journal of steroid biochemistry (01-04-1984)
    “…RU 16117, the 11 alpha-methoxy derivative of ethynyl estradiol, is an orally active weak estrogen potentially effective in the treatment of estrogen-deficiency…”
    Get more information
    Journal Article
  16. 16

    Elastic response in wood under moisture content variations: analytic development by Husson, J. M., Dubois, F., Sauvat, N.

    Published in Mechanics of time-dependent materials (01-05-2010)
    “…Creep evolution of timber structures results from the interaction between mechanical stresses due to different loads and hydric stresses due to moisture…”
    Get full text
    Journal Article
  17. 17

    New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen by Labrie, F, Dupont, A, Belanger, A, Cusan, L, Lacourciere, Y, Monfette, G, Laberge, J G, Emond, J P, Fazekas, A T, Raynaud, J P, Husson, J M

    “…In order to block the influence of androgens from all sources on the growth of prostatic cancer, we have used a new hormonal therapy based on medical…”
    Get more information
    Journal Article
  18. 18

    Interaction between roxithromycin and cyclosporin in heart transplant patients by BILLAUD, E. M, GUILLEMAIN, R, FORTINEAU, N, KITZIS, M.-D, DREYFUS, G, AMREIN, C, KREFT-JAIÊS, C, HUSSON, J.-M, CHRETIEN, P

    Published in Clinical pharmacokinetics (01-12-1990)
    “…Cyclosporin is an immunosuppressive agent commonly used in transplant patients. It is actively metabolised by the cytochrome P450 system and interactions with…”
    Get full text
    Journal Article
  19. 19

    Hormonal and metabolic effects of somatostatin in diabetic patients submitted to an i.v. arginine infusion by Assan, R, Heuclin, C, Girard, J R, Basdevant, A, Predine, J, Husson, J M

    Published in Diabete & metabolisme (01-03-1977)
    “…Hormonal and metabolic effects of a synthetic linear somatostatin were tested in insulin-dependent subjects submitted to an intravenous arginine infusion…”
    Get more information
    Journal Article
  20. 20

    Hepatocyte giant mitochondria: an almost constant lesion in systemic scleroderma by Feldmann, G, Maurice, M, Husson, J M, Fiessinger, J N, Camilleri, J P, Benhamou, J P, Housset, E

    “…Liver electron microscopic studies were performed in 14 patients with systemic scleroderma. In 13 of these patients, giant mitochondria were demonstrated in…”
    Get full text
    Journal Article